Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

V disease and is administered by intramuscular injection. The safety and efficacy of Synagis were established in infants with bronchopulmonary dysplasia (BPD), infants with a history of prematurity (less than or equal to 35 weeks gestational age), and children with hemodynamically significant congenital heart disease. The first dose of Synagis should be administered prior to commencement of the RSV season, which usually starts in the fall and runs through the spring. Patients, including those who develop an RSV infection, should continue to receive monthly doses throughout the season.

Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe hypersensitivity reactions occurred on initial exposure or re-exposure. If a severe hypersensitivity reaction occurs, therapy with Synagis should be permanently discontinued. If milder hypersensitivity reaction occurs, caution should be used on re-administration of Synagis.

In clinical trials, the most common adverse events occurring at least one percent more frequently in Synagis-treated patients than controls were upper respiratory infection, otitis media, fever and rhinitis. Cyanosis and arrhythmia were seen in children with CHD.

The pivotal trial for Synagis was called the IMpact trial and comprised a total of 1,502 children who were randomized (500 placebo, 1,002 Synagis) in a double-blind, placebo-controlled protocol where 1,486 children completed the study's follow-up.

In the IMpact trial, monthly prophylaxis with Synagis via intramuscular injections was associated with a 55-percent reduction in hospitalization as a result of RSV (p=<0.001). Reductions were observed in both children with bronchopulmonary dysplasia (38 percent reduction) and premature children without BPD (78 percent reduction). Approximately 50 percent of the
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... LAKE CITY , March 31, 2015  Cindy Dellecker, ... Plan Operations at Highmark Inc., has accepted a position ... years of experience in managed care to TruHearing and ... continued growth and expansion. "Hearing healthcare ... both a professional and a personal level," said Dellecker. ...
(Date:3/30/2015)... , 31 mars 2015  Une équipe de ... structure atomique d,un récepteur de surface cellulaire ... formation de thromboses. Contre toute attente, cette ... nouvelles caractéristiques structurelles qui remettent en cause ... sur les récepteurs couplés aux protéines G ...
(Date:3/30/2015)... March 30, 2015 TapImmune Inc . ... at the Fifth Annual "Cancer Immunotherapy: A Long-Awaited Reality" conference ... New York City on March 26. ... Glynn Wilson , Chairman & CEO of TapImmune and ... Company.  Regrettably, due to parallel meeting sessions running behind schedule, Dr. ...
Breaking Medicine Technology:TruHearing Announces Addition of Cindy Dellecker to Advisory Board 2De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 2De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 3Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 2Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 3
... Accuray Incorporated (Nasdaq: ARAY ), ... received the NorthFace ScoreBoard Award(SM) (NFSB ... recognition of achieving excellence in customer service and support in ... Accuray is the first organization also to qualify for outstanding ...
...  Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX ) announced today ... Cowen and Company 32nd Annual Healthcare Conference on March 7, ... Place, Massachusetts; the 24th Annual Roth Conference on March 12, ... Niguel, California; and the Barclays Capital Global Healthcare Conference on ...
Cached Medicine Technology:Accuray Recognized for Delivering 'World-Class' Customer Service 2Accuray Recognized for Delivering 'World-Class' Customer Service 3Accuray Recognized for Delivering 'World-Class' Customer Service 4
(Date:3/31/2015)... 31, 2015 A team of Italian ... with anti-cancer properties, into mesothelioma cancer cells. Surviving Mesothelioma ... on its website. Click here to read it ... yellow color to the spice turmeric, has limited value ... Biomaterials experts at Università di Napoli Federico II are ...
(Date:3/31/2015)... Texas (PRWEB) March 31, 2015 ... oxygen therapy equipment and supplies, was recently selected to ... identify online merchants that offer a great shipping experience, ... sites that demonstrate a track record of on-time shipping ... Inc. website, shoppers will see a Google Trusted Store ...
(Date:3/31/2015)... March 31, 2015 According to data ... start their own businesses fail within the first 18 ... up to change those numbers for the better. ... based out of the Mahoning Valley in Ohio. YBI ... by offering clients guidance on topics such as management ...
(Date:3/31/2015)... March 31, 2015 If you or ... the U.S. suffering from Irritable Bowel Syndrome (IBS), you ... Act" airing on Lifetime Television® at 7:30am EDT/PDT on ... episode will include an informative health segment featuring interviews ... Disease Christine Frissora, MD and Medical Scientist Victoria Jaison, ...
(Date:3/31/2015)... . All the work that is done is ... laid upon helping our clients in maintaining their confident beautiful ... teeth and this problem needs to be addressed as soon ... play a key role in shattering one’s confidence but they ... the importance of this problem, Lewis Clinic has started dental ...
Breaking Medicine News(10 mins):Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Sleep Restfully, Inc. now recognized as Google Trusted Store 2Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 2Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 3Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 2Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 3Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 4
... Davis MIND Institute researchers will lead a symposium on ... development of autism in children during the American Association ... 16 -18 in Vancouver, Canada. The symposium, "Autism: ... be held Feb. 18. The researchers, both affiliated with ...
... disease drugs now being tested in clinical trials may ... Medicine research. A study with mice suggests the drugs ... be miswired and interfering with their ability to send ... scientist whose original research led to the drug development, ...
... SATURDAY, Feb. 18 (HealthDay News) -- Pregnant women who own a ... minutes of exercise a day by going for brisk walks, a ... a dog could be part of a wider strategy to combat ... at the University of Liverpool in the U.K. The findings ...
... international health at the Swedish medical university Karolinska Institutet ... as a lecturer at international science conferences and as ... next scheduled appearance is in a panel debate at ... February. The theme of the conference is "Flattening the ...
... die on the job in the U.S. each year, and ... Georgia study, a worker,s perception of safety in the workplace ... effect on on-the-job injury. "We,ve known for some time ... a variety of physical and other hazards," said Dave DeJoy, ...
... Foundation again has demonstrated its commitment to University Hospitals ... Institute. The gift will honor the late Benjamin L. ... of Prentiss Foundation trustee Elisabeth Alexander. ... in 1893 helped found what is known today as ...
Cached Medicine News:Health News:UC Davis MIND Institute researchers to present on autism at AAAS Annual Meeting in Vancouver 2Health News:Alzheimer's drugs may have adverse side effects 2Health News:Dogs Can Boost Exercise Rates for Moms-to-Be 2Health News:Professor from Karolinska Institutet now international educator 2Health News:Perception, work-life balance key factors in workplace safety, says UGA study 2Health News:Perception, work-life balance key factors in workplace safety, says UGA study 3Health News:University Hospitals receives $5 million gift for Eye Institute 2Health News:University Hospitals receives $5 million gift for Eye Institute 3
MP-250N and 300N is a new style power supply. It is a versatile microprocessor power supply for horizontal or vertical gel electrophoresis. The unit is programmable and offers constant voltage and co...
... The ZOOM® Dual Power is ... of running both high voltage/low current ... The high voltage/low current section is ... IEF, and DNA sequencing applications. The ...
... The PowerEase® 500 Power Supply ... electrophoresis. It offers extensive programming ... four custom methods for you ... preferences. The simple intuitive PowerEase ...
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
Medicine Products: